Can granulocyte colony stimulating factor (G-CSF) ameliorate acetaminophen-induced hepatotoxicity?

Area of Science:

• Hepatology and Toxicology
• Pharmacology and Drug Development

Background:

• Acetaminophen (APAP) overdose is a leading cause of acute liver injury and failure.
• Current treatments like N-acetylcysteine (N-AC) are effective but new strategies are needed.
• APAP hepatotoxicity involves oxidative stress, inflammation, and hepatocyte necrosis.

Purpose of the Study:

• To investigate the potential hepatoprotective effects of granulocyte colony stimulating factor (G-CSF) against APAP-induced liver injury.
• To compare the efficacy of G-CSF with N-AC in mitigating APAP toxicity in a rat model.

Main Methods:

• APAP-induced hepatotoxicity was established in Wistar rats.
• Serum liver enzymes (ALT, AST, ALP, LDH) and hepatic oxidative stress markers (MDA, NO, GSH, CAT) were measured.
• Histological analysis assessed liver damage and inflammation.
• Rats were treated with N-AC or G-CSF post-APAP administration.

Main Results:

• APAP administration significantly elevated liver enzymes and oxidative stress markers, consistent with histological liver damage.
• Both N-AC and G-CSF treatments reduced serum ALT, AST, and LDH levels, and decreased MDA and NO levels.
• G-CSF and N-AC maintained GSH content and CAT activity, attenuated inflammation, and reduced hepatocyte necrosis.
• G-CSF demonstrated comparable or superior hepatoprotective effects to N-AC in this model.

Conclusions:

• G-CSF is a potential alternative hepatoprotective agent against APAP-induced acute liver injury.
• G-CSF mitigates APAP toxicity by reducing oxidative stress and inflammation.
• Further clinical investigation of G-CSF for APAP overdose is warranted.